These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10293974)

  • 21. Effective decision-making in a changing healthcare environment: a P & T Committee interview.
    Zoloth A; Yon JL; Woolf R
    Hosp Formul; 1989 Feb; 24(2):85-7, 90, 93 passim. PubMed ID: 10291815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Communicating P & T guidelines: how one committee meets the challenge.
    Dreyfus R; Bender F
    Hosp Formul; 1987 Jul; 22(7):651-4, 657. PubMed ID: 10282681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wisconsin hospital finds creative ways to reduce ADEs; avoids the "quick fix" approach.
    Health Care Cost Reengineering Rep; 1999 Jun; 4(6):85-9. PubMed ID: 10538675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P & T Committee interview: communication and education contribute to an effective formulary system.
    Hinthorn D; Godwin H
    Hosp Formul; 1989 May; 24(5):281-4, 286-7. PubMed ID: 10292977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Staggered dosing chart improves i.v. antibiotic scheduling.
    Qual Lett Healthc Lead; 1997 Feb; 9(2):17-9. PubMed ID: 10166199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dosing guidelines for foscarnet and trimetrexate.
    Wooten JM; Chase K; O'Connor MC; Henry RB
    Formulary; 1995 Jun; 30(6):349-52. PubMed ID: 10144874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New England Deaconess guidelines for the administration of i.v. drugs.
    Sesin P; Wiggins MS
    NITA; 1987; 10(3):224-34. PubMed ID: 3648519
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of the use of i.v. ciprofloxacin.
    Sesin GP; Stefanski L
    Hosp Formul; 1992 Oct; 27(10):1053-4. PubMed ID: 10121420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Written policy needed to limit use of dangerous drugs.
    Bowles GC
    Mod Hosp; 1968 Apr; 110(4):132. PubMed ID: 5644545
    [No Abstract]   [Full Text] [Related]  

  • 30. Distribution plan for immune globulin intravenous during a shortage.
    Connelly JF; Verzino KC
    Am J Health Syst Pharm; 1999 Aug; 56(15):1546-8. PubMed ID: 10478995
    [No Abstract]   [Full Text] [Related]  

  • 31. Implementation of an off-site mobile pharmacy cart to reduce medication turnaround time.
    Sveska KJ; Hoffman RP; Bohl BS
    Hosp Pharm; 1986 Sep; 21(9):883-5. PubMed ID: 10278989
    [No Abstract]   [Full Text] [Related]  

  • 32. Potassium and phosphorus repletion in hospitalized patients: implications for clinical practice and the potential use of healthcare information technology to improve prescribing and patient safety.
    Hemstreet BA; Stolpman N; Badesch DB; May SK; McCollum M
    Curr Med Res Opin; 2006 Dec; 22(12):2449-55. PubMed ID: 17257459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.
    Cramer R; Wright C
    Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights from the sharp end of intravenous medication errors: implications for infusion pump technology.
    Husch M; Sullivan C; Rooney D; Barnard C; Fotis M; Clarke J; Noskin G
    Qual Saf Health Care; 2005 Apr; 14(2):80-6. PubMed ID: 15805451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pharmacy quality assurance program.
    Zelonis A; Fleischer N; Walling R
    Hosp Formul; 1979 Feb; 14(2):205, 208-9, 211. PubMed ID: 10308795
    [No Abstract]   [Full Text] [Related]  

  • 36. Factors predictive of intravenous fluid administration errors in Australian surgical care wards.
    Han PY; Coombes ID; Green B
    Qual Saf Health Care; 2005 Jun; 14(3):179-84. PubMed ID: 15933314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An approach to cost-effective antibiotic utilization.
    Venezio FR; Waitley DW
    Hosp Formul; 1988 Dec; 23 Suppl D():32-5. PubMed ID: 10312796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barcode medication. Administration implementation in an acute care hospital and lessons learned.
    Agrawal A; Glasser AR
    J Healthc Inf Manag; 2009; 23(4):24-9. PubMed ID: 19894483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An institutional approach to developing guidelines for the use of low-osmolality contrast agents.
    Swanson DP
    Appl Radiol; 1988 May; 17(5):27-8. PubMed ID: 10287384
    [No Abstract]   [Full Text] [Related]  

  • 40. Strategies for reducing i.v. drug waste and coping with increased workload.
    Hoolihan RJ; Erickson BA
    Hosp Pharm; 1987 Sep; 22(9):871-6. PubMed ID: 10312222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.